(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...
(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...
...
Geert R Kersten, Director and CEO, purchased 25,000 shares of Cel-Sci (CVM) on Jul 06, 2021, for $200,000. After the Form 4 filing with the SEC, Kersten...
| Address | 8229 Boone Boulevard Vienna, Virginia 22182 |
| Phone | +1.703.506.9460 |
| Number of Employees | N/A |
| Recent SEC Filing | 05/13/2022 10-Q |
| CEO, Chief Financial Officer, Treasurer & Director | Geert R. Kersten |
| Secretary & Senior Vice President-Operations | Patricia B. Prichep |
| Chief Scientific Officer | Eyal Talor |
| Vice President-Quality Assurance | William Jones |
| Price Open | $3.02 |
| Previous Close | $2.92 |
| 52 Week Range | $2.49 - 27.28 |
| Market Capitalization | $141.7 M |
| Shares Outstanding | 43.3 M |
| Sector | Health Technology |
| Industry | Biotechnology | Next Earnings Announcement | 08/15/2022 |
| Call Open Interest (1d)* |  |
| Put Open Interest (1d)* | |
| Call Volume (1d)* | |
| Put Volume (1d)* | |
| Put Call Open Interest Ratio (1d)* | |
| Put Call Volume Ratio (1d)* | |
| * Data delayed by up to 15 minutes |
| Price / Earnings | N/A |
| Earnings per Share | -$0.87 |
| Beta vs. S&P 500 | N/A |
| Revenue | $476.6 K |
| Net Profit Margin | N/A |
| Return on Equity | -75.54% |
| Buy | |
| Overweight | |
| Hold | |
| Underweight | |
| Sell | |
Consensus Recommendation | |
